Aristea Therapeutics Revenue and Competitors

Location

$117.6M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Aristea Therapeutics's estimated annual revenue is currently $1.3M per year.(i)
  • Aristea Therapeutics's estimated revenue per employee is $77,500
  • Aristea Therapeutics's total funding is $117.6M.

Employee Data

  • Aristea Therapeutics has 17 Employees.(i)
  • Aristea Therapeutics grew their employee count by 13% last year.

Aristea Therapeutics's People

NameTitleEmail/Phone
1
Chief Medical OfficerReveal Email/Phone
2
Senior Director, Clinical OperationsReveal Email/Phone
3
Senior Director, Operations & Business DevelopmentReveal Email/Phone
4
President & CEOReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Aristea Therapeutics?

Aristea Therapeutics (Air-iss-tay-uh) is a clinical-stage drug development company developing novel therapies to treat serious inflammatory diseases. The Aristea team is leveraging its broad industry expertise and proven success in drug development to form synergistic partnerships and build a pipeline of novel drugs. Aristea’s lead program, RIST4721, is currently in Phase 2 clinical development.

keywords:N/A

$117.6M

Total Funding

17

Number of Employees

$1.3M

Revenue (est)

13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Aristea Therapeutics News

2022-03-30 - Clinical Catch-Up: Adagio to Seek COVID-19 EUA, CytoDyn's ...

Aristea Therapeutics dosed the first patient in its Phase IIb trial of RIST4721 in palmoplantar pustulosis. The drug is a CXCR2 antagonist.

2022-03-22 - Aristea Therapeutics Announces Dosing of First Patient in ...

Aristea Therapeutics (Air-iss-tay-uh) is a clinical-stage immunology focused drug development company developing novel therapies to treat...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.8M176%$21.4M
#2
$3.6M17N/AN/A
#3
$1.5M17N/AN/A
#4
$1.5M17N/AN/A
#5
$1.5M17N/AN/A